Skip to main content
    A

    Arcturus Therapeutics Holdings Inc (ARCT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.31
    -0.05 (-0.60%)

    Market Cap: $240.96M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Arcturus Therapeutics Holdings Inc (ARCT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Arcturus Therapeutics Holdings are Rocket Pharmaceuticals (RCKT), ARS Pharmaceuticals (SPRY) and ProQR Therapeutics BV (PRQR). By market cap, Arcturus Therapeutics Holdings ranks 5th of the 13 companies on this page; ARS Pharmaceuticals (SPRY) is the largest at $391.06M.

    Peer Comparison

    ARCT's revenue growth of 6.7% is below the peer median of 18.6%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Arcturus Therapeutics Holdings (ARCT)$240.96MN/A7.7x-285.9%N/A6.7%0.00%
    Rocket Pharmaceuticals Inc (RCKT)$256.82MN/AN/A0.0%-2.3%0.0%0.00%
    ARS Pharmaceuticals, Inc (SPRY)$391.06MN/A2.9x-163.6%-143.8%16.0%0.00%
    ProQR Therapeutics BV (PRQR)$199.28MN/A6.1x-228.2%N/A120.4%0.00%
    Entrada Therapeutics Inc (TRDA)$199.28MN/A53.3x0.0%-69.7%-43.9%0.00%
    Larimar Therapeutics Inc (LRMR)$313.73MN/AN/A0.0%N/A0.0%0.00%
    Invivyd Inc. (IVVD)$171.58MN/A2.9x-183.9%N/A21.2%0.00%
    Protara Therapeutics Inc (TARA)$155.77MN/AN/A0.0%N/A0.0%0.00%
    Keros Therapeutics Inc (KROS)$202.13MN/A4.9x-151.4%N/A180.5%0.00%
    Armata Pharmaceuticals Inc (ARMP)$143.94MN/A14.7x0.0%-184.6%173.6%0.00%
    Prelude Therapeutics Inc (PRLD)$275.32MN/A16.3x-269.7%N/A41.0%0.00%
    Bicycle Therapeutics Ltd (BCYC)$236.22MN/A2.7x-169.8%N/A190.2%0.00%
    Immuneering Corp (IMRX)$240.27MN/AN/A0.0%N/A-99.8%0.00%
    Peer median$219.17MN/A5.5x-75.7%-106.8%18.6%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Arcturus Therapeutics Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Rocket Pharmaceuticals Inc (RCKT)
    Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases.
    RCKT competitors
    ARS Pharmaceuticals, Inc (SPRY)
    ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine aerosol with absorption technology for patients and their families at risk of severe...
    SPRY competitors
    ProQR Therapeutics BV (PRQR)
    ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders.
    PRQR competitors
    Entrada Therapeutics Inc (TRDA)
    Entrada Therapeutics Inc. (TRDA) is a forward-thinking biotechnology company focused on creating innovative therapies for severe diseases characterized by...
    TRDA competitors
    Larimar Therapeutics Inc (LRMR)
    Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases.
    LRMR competitors
    Invivyd Inc. (IVVD)
    Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery...
    IVVD competitors
    Protara Therapeutics Inc (TARA)
    Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment...
    TARA competitors
    Keros Therapeutics Inc (KROS)
    Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery...
    KROS competitors
    Armata Pharmaceuticals Inc (ARMP)
    Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of specific bacteriophage therapies for the treatment...
    ARMP competitors
    Prelude Therapeutics Inc (PRLD)
    Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized...
    PRLD competitors
    Bicycle Therapeutics Ltd (BCYC)
    Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments.
    BCYC competitors
    Immuneering Corp (IMRX)
    Immuneering Corp (IMRX) is a cutting-edge biotechnology firm dedicated to advancing targeted therapeutics for cancer and other critical illnesses through its...
    IMRX competitors

    Frequently Asked Questions About ARCT

    Who are Arcturus Therapeutics Holdings' main competitors?

    The companies most similar to Arcturus Therapeutics Holdings include Rocket Pharmaceuticals (RCKT), ARS Pharmaceuticals (SPRY), ProQR Therapeutics BV (PRQR), Entrada Therapeutics (TRDA) and Larimar Therapeutics (LRMR), listed from the closest match.

    Who is Arcturus Therapeutics Holdings' biggest competitor?

    ARS Pharmaceuticals (SPRY) is the largest of the similar companies at $391.06M; Rocket Pharmaceuticals (RCKT) is the closest match by business profile, size, sector and industry.

    How does ARCT stock compare with its competitors?

    ARCT's P/S is 7.7x against a peer median of 5.5x; its net margin is -285.9% against a peer median of -75.7%.

    Which of Arcturus Therapeutics Holdings' competitors pays a higher dividend?

    Arcturus Therapeutics Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Arcturus Therapeutics Holdings bigger than its competitors?

    No. Arcturus Therapeutics Holdings is 5th by market cap among the 13 companies on this page; the largest is ARS Pharmaceuticals (SPRY) at $391.06M.